Literature DB >> 33295029

Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?

Sotirios Nedios1, Michael Doering1, Angeliki Darma1, Johannes Lucas1, Borislav Dinov1, Arash Arya1, Nikolaos Dagres1, Gerhard Hindricks1, Andreas Bollmann1, Sergio Richter1, Kerstin Bode1.   

Abstract

BACKGROUND: Cardiac resynchronization therapy (CRT) is widely used in atrial fibrillation (AF) patients and could impact rhythm stability. HYPOTHESIS: We aimed to identify predictors of sinus rhythm (SR) stability or AF progression in a real-word cohort of CRT-AF patients.
METHODS: From 330 consecutive implantable cardioverter-defibrillator implantations due to ischemic or dilated cardiomyopathy, 65 (20%) patients with AF history (paroxysmal, n = 32) underwent a CRT implantation with an atrial electrode and were regularly followed every 4-6 months. Rhythm restoration was attempted for most AF patients based on symptoms, biventricular pacing (BP), and lack of thrombi.
RESULTS: After 33 months, 18 (28%) patients progressed to permanent mode switch (MS≥99%) and 20 (31%) patients had stable SR (MS < 1%). Logistic regression showed that history of persistent AF (OR: 8.01, 95%CI: 2.0-31.7, p = .003) is associated with higher risk of permanent MS. In persistent AF patients, a bigger left atrium (OR: 1.2 per mm, 95%CI: 1.03-1.4, p = .025) and older age (OR: 1.15 per life-year, 95%CI: 1.01-1.3, p = .032) were predictors of future permanent MS. Paroxysmal AF at implantation (OR: 5.96, 95%CI: 1.6-21.9, p = .007) and increased BP (OR: 1.4 per 1%, 95%CI: 1.05-1.89, p = .02) were associated with stable SR. In persistent AF patients, stable SR correlated with higher BP (98 ± 2 vs. 92 ± 8%, p < .001).
CONCLUSION: In patients with AF undergoing CRT implantation, persistent AF, LA dilatation and advanced age relate to future permanent MS (AF), whereas high BP promotes SR stability. These findings could facilitate the management of CRT-AF patients and guide therapy in order to maximize its effect on rhythm.
© 2020 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.

Entities:  

Keywords:  ICD; LA diameter; age; atrial fibrillation; atrial lead; cardiac resynchronization

Year:  2020        PMID: 33295029      PMCID: PMC7852157          DOI: 10.1002/clc.23527

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  26 in total

1.  Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm.

Authors:  P Kiès; C Leclercq; G B Bleeker; C Crocq; S G Molhoek; C Poulain; L van Erven; M Bootsma; K Zeppenfeld; E E van der Wall; J-C Daubert; M J Schalij; J J Bax
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey.

Authors:  Maria Grazia Bongiorni; Alessandro Proclemer; Dan Dobreanu; Germanas Marinskis; Laurent Pison; Carina Blomstrom-Lundqvist
Journal:  Europace       Date:  2013-11       Impact factor: 5.214

Review 3.  Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review.

Authors:  Anand N Ganesan; Anthony G Brooks; Kurt C Roberts-Thomson; Dennis H Lau; Jonathan M Kalman; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2012-02-21       Impact factor: 24.094

4.  Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival.

Authors:  David L Hayes; John P Boehmer; John D Day; F R Gilliam; Paul A Heidenreich; Milan Seth; Paul W Jones; Leslie A Saxon
Journal:  Heart Rhythm       Date:  2011-04-15       Impact factor: 6.343

5.  On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: A secondary analysis of the His-SYNC Pilot Trial.

Authors:  Gaurav A Upadhyay; Pugazhendhi Vijayaraman; Hemal M Nayak; Nishant Verma; Gopi Dandamudi; Parikshit S Sharma; Moeen Saleem; John Mandrola; Davide Genovese; Jess W Oren; Faiz A Subzposh; Zaid Aziz; Andrew Beaser; Dalise Shatz; Stephanie Besser; Roberto M Lang; Richard G Trohman; Bradley P Knight; Roderick Tung
Journal:  Heart Rhythm       Date:  2019-05-13       Impact factor: 6.343

6.  Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study.

Authors:  Maurizio Gasparini; Jonathan S Steinberg; Aysha Arshad; François Regoli; Paola Galimberti; Arnaud Rosier; Jean Claude Daubert; Catherine Klersy; Ganesh Kamath; Christophe Leclercq
Journal:  Eur Heart J       Date:  2010-01-12       Impact factor: 29.983

7.  Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies.

Authors:  Jedrzej Kosiuk; Sotirios Nedios; Angeliki Darma; Sascha Rolf; Sergio Richter; Arash Arya; Christopher Piorkowski; Thomas Gaspar; Philipp Sommer; Daniela Husser; Gerhard Hindricks; Andreas Bollmann
Journal:  Europace       Date:  2014-02-13       Impact factor: 5.214

8.  The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.

Authors:  Kevin T Ousdigian; P Peter Borek; Jodi L Koehler; J Thomas Heywood; Paul D Ziegler; Bruce L Wilkoff
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-05-17

9.  Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.

Authors:  Julia Köbe; Kristina Wasmer; Dietrich Andresen; Thomas Kleemann; Stefan G Spitzer; Joachim Jehle; Johannes Brachmann; Christoph Stellbrink; Matthias Hochadel; Jochen Senges; Helmut U Klein; Lars Eckardt
Journal:  Int J Cardiol       Date:  2013-08-12       Impact factor: 4.164

10.  Clinical characteristics, mortality, cardiac hospitalization, and ventricular arrhythmias in patients undergoing CRT-D implantation: results of the ACTION-HF study.

Authors:  Giovanni Luca Botto; Cosimo Damiano Dicandia; Massimo Mantica; Concetto La Rosa; Antonio D'Onofrio; Maria Grazia Bongiorni; Giulio Molon; Roberto Verlato; Giovanni Quinto Villani; Alberto Scaccia; Giovanni Raciti; Eraldo Occhetta
Journal:  J Cardiovasc Electrophysiol       Date:  2012-11-06
View more
  1 in total

1.  Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?

Authors:  Sotirios Nedios; Michael Doering; Angeliki Darma; Johannes Lucas; Borislav Dinov; Arash Arya; Nikolaos Dagres; Gerhard Hindricks; Andreas Bollmann; Sergio Richter; Kerstin Bode
Journal:  Clin Cardiol       Date:  2020-12-09       Impact factor: 2.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.